Cytotoxicity of the Traditional Chinese Medicine (TCM) Plumbagin in Its Copper Chemistry
Overview
Authors
Affiliations
The anticancer traditional Chinese medicine (TCM), plumbagin (PLN), was isolated from Plumbago Zeylanica. Reaction of plumbagin with Cu(II) salt, afforded [Cu(PLN)(2)].2H(2)O (1). With 2,2'-bipyridine (bipy) as a co-ligand, PLN reacts with Cu(II) to give [Cu(PLN)(bipy)(H(2)O)](2)(NO(3))(2).4H(2)O (2). 1 and 2 were characterized by elemental analysis, IR, ESI-MS spectra. Their crystal structures were determined by single crystal X-ray diffraction methods. The in vitro cytotoxicity of PLN, 1 and 2 against seven human tumour cell lines was assayed. The metal-based compounds exhibit enhanced cytotoxicity vs. that of free PLN, suggesting that these compounds display synergy in the combination of metal ions with PLN. The binding properties of PLN, 1 and 2 to DNA were investigated through UV-vis, fluorescence, CD spectra, and gel mobility shift assay, which indicated that 1 and 2 were non-covalent binding and mainly intercalated the neighboring base pairs of DNA. PLN, 1 and 2 exhibit inhibition activity to topoisomerase I (TOPO I), but 1 and 2 were more effective than PLN.
Biological potential of copper complexes: a review.
Ashraf J, Riaz M Turk J Chem. 2023; 46(3):595-623.
PMID: 37720617 PMC: 10503981. DOI: 10.55730/1300-0527.3356.
Mukherjee S, Sawant A, Prassanawar S, Panda D ACS Omega. 2023; 8(3):3221-3235.
PMID: 36713695 PMC: 9878539. DOI: 10.1021/acsomega.2c06691.
Arjmand F, Afsan Z, Roisnel T RSC Adv. 2022; 8(65):37375-37390.
PMID: 35557803 PMC: 9089433. DOI: 10.1039/c8ra06722h.
A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity.
de Medeiros W, de Medeiros M, Carvalho E, de Lima J, Oliveira V, de B Pontes A RSC Adv. 2022; 8(30):16873-16886.
PMID: 35540529 PMC: 9080323. DOI: 10.1039/c8ra03626h.
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.
Molinaro C, Martoriati A, Pelinski L, Cailliau K Cancers (Basel). 2020; 12(10).
PMID: 33027952 PMC: 7601307. DOI: 10.3390/cancers12102863.